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These guidelines do not establish a standard of care to be followed in every case. It is
recognized that each case is different and those individuals involved in providing health care are
expected to use their judgment in determining what is in the best interests of the patient based
on the circumstances existing at the time. It is impossible to anticipate all possible situations
that may exist and to prepare guidelines for each. Accordingly, these guidelines should guide
care with the understanding that departures from them may be required at times.

January 20, 2016
Algorithm:

Evaluation of a Child Who Presents to the
Emergency Department or Urgent Care Center
After a Simple Febrile Seizure
(age 6 months to 60 months)

Obtain a History
and Physical

Is the diagnosis of a
seizure likely?

Differential Diagnoses
· Syncope during febrile states
· Abnormal motor manifestations
such as shuddering, dystonia
· Rigors
· Toxic ingestion

No

Yes

Identify and treat the source of the fever

Provide
· Anticipatory guidance
· Kid’s Health materials -available in
Depart process at CMH
· Arrange follow up with Primary Care
Provider

Discharge

·
·
·
·
·
·

NOT recommended:
Laboratory tests
Lumbar puncture
EEG
CT Scan
MRI
Medications

Epidemiology:
Febrile seizures are seizures that happen during a febrile illness in 6 month olds to 60 months. Simple
febrile seizures represent those that are brief, singular, and generalized, occurring in otherwise
neurodevelopmentally healthy children, without any other infection that affects the brain, such as
meningitis or abscess. These are common, occurring in 1/25 children, and represent the most
common neurological disorder of childhood.
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The primary goal is to determine the cause of the fever and treat it appropriately, and therefore
medications for the seizure are not recommended, but medications to treat the causative infection are
recommended.
Objective of the Guideline: The objective of this guideline is to standardize care of the child with a
simple febrile seizure in the Emergency Department/ Urgent Care (ED ED/UCC) setting.
Target Users: ED/UCC providers including physicians, fellow, resident physicians, advance practice
nurses and direct care nurses.
Guideline Inclusion Criteria:
· Children 6 months to 60 months
· Neurodevelopmentally normal
· Seizures are less than 5 minutes
· Seizures occur once within a 24 hour period
Guideline Exclusion Criteria:
· Presence of:
o Intracranial infection
o Known underlying condition, such as and inborn error of metabolism
o History of afebrile seizures
o Recent history of head trauma
Differential Diagnosis:
· Includes:
o Syncope during febrile states
o Abnormal motor manifestations such as shuddering, dystonic seizures
o Rigors
o Toxic ingestion
Clinical Questions Answered by Guideline:
1. Should a child seen in the ED/UCC with a simple febrile seizure:
a) Have laboratory tests performed?
b) Have radiological imaging (CT)?
c) Have an EEG performed?
d) Be treated with medications?
e) Be sent home with medications?
f) Have a neurology consult?
g) Be admitted to the hospital?
1. Should a lumbar puncture and laboratory testing of CFS be done for children with a simple febrile
seizure?
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Search Strategies:
Question

Lab tests

Search Strategy
PubMed- ("Seizures, Febrile/blood"[Mesh] OR "Seizures, Febrile/diagnosis"[Mesh] OR
"Seizures, Febrile/epidemiology"[Mesh] OR "Seizures, Febrile/etiology"[Mesh]) AND
("CBC"[tiab] OR "BMP"[tiab] OR "CMP"[tiab] OR "Blood Cell Count"[Mesh] OR
"Glucose/blood"[Mesh] OR "Clinical Laboratory Techniques"[Mesh] OR
"Sodium/blood"[Mesh] OR "Magnesium/blood"[Mesh] OR "Phosphorus/blood"[Mesh] OR
"Biological Markers/blood"[Mesh] OR "Calcium/blood"[Mesh] OR "Water-Electrolyte
Imbalance/blood"[Mesh] OR "Electrolytes/blood"[Mesh] OR "Hypoglycemia/blood"[Mesh]
OR "Hyperglycemia/blood"[Mesh] OR "Blood Sedimentation"[Mesh] OR "C-Reactive
Protein/blood"[Mesh] OR "Leukocyte Count"[Mesh] OR "laboratory studies"[All Fields] OR
"laboratory"[tiab]) AND ("2010/01/01"[PDAT] : "2015/12/31"[PDAT]) 63 results
PubMed-("Seizures, Febrile/radiography"[Mesh] OR "Seizures, Febrile/radionuclide
imaging"[Mesh]) OR ("Seizures, Febrile"[Majr] AND ("Neuroimaging"[Mesh] OR "Diagnostic
Imaging"[Majr])) AND (("2010/01/01"[PDAT] : "2015/12/31"[PDAT]) AND "humans"[MeSH
Terms] AND English[lang] AND ("infant"[MeSH Terms] OR "child"[MeSH Terms] OR
"adolescent"[MeSH Terms])) 11 results

Imaging

EEG

Treated
with meds
in the ED
and
discharged
with
medications

EMBASE Terms
Results
# 3 AND ([adolescent]/lim OR [child]/lim OR [infant]/lim OR
9
#4
[newborn]/lim) AND 2010:py OR 2011:py OR 2012:py OR 2013:py
OR 20140:py) AND [embase]/lim NOT [medline]/kun
68
#3
#1 AND #2
#2
‘febrile convulsion/exp/mj OR ‘imaging and display/ exp/mj
331627
#1
”febrile convulsion”/exp/mj
2824
PubMed-"Seizures, Febrile"[Majr] AND ("Electroencephalography"[Mesh] OR "EEG"[tiab])
NOT (Editorial[ptyp] OR Letter[ptyp] OR Case Reports[ptyp]) AND (("2010/01/01"[PDAT] :
"2015/12/31"[PDAT]) AND "humans"[MeSH Terms] AND English[lang] AND ("infant"[MeSH
Terms] OR "child"[MeSH Terms] OR "adolescent"[MeSH Terms])) Filters: From 2010/01/01
to 2015/12/31, Humans, English, Child: birth-18 years 30 results
EMBASE Terms
#9 #8 AND ([adolescent]/lim OR [child]/lim OR [infant]/lim OR
[newborn]/lim) AND (2010:py OR 2011:py OR 2012:py OR 2013:py
OR 2014:py OR2015:py) AND [embase]/lim NOT [medline]/lim
# 8 ‘febrile convulsion/exp/mj AND “electroencephalogram’/exp
PubMed:

Results
35

224

("Seizures, Febrile/drug therapy"[Mesh] OR "Seizures, Febrile/prevention and
control"[Mesh]) AND ("2010/01/01"[PDAT] : "2015/12/31"[PDAT]) AND ("humans"[MeSH
Terms] AND English[lang] AND ("infant"[MeSH Terms] OR "child"[MeSH Terms] OR
"adolescent"[MeSH Terms])) 35 results. April 16 2015
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Neuro
consult
Be
admitted to
the hospital

LP

No results

No results

PubMed -("Seizures, Febrile/cerebrospinal fluid"[Mesh]) AND ("Seizures, Febrile"[Mesh]
AND ("Spinal Puncture"[Mesh] OR "lumbar puncture"[tiab] OR "Cerebrospinal
Fluid"[Mesh])) Filters: From 2010/01/01 to 2015/12/31 4 Results
EMBASE
Results
#5
#4 AND (2010:py OR 2011:py OR 2012:py OR 2013:py OR 2014:py)
AND [embase]/lim NOT [medline]/lim
24
#2 AND #3
6004
#3 'febrile convulsion'/exp
2985
#2 'lumbar puncture'/exp AND 'cerebrospinal fluid'/exp
An ancestry search of the AAP Taskforce statement yielded two additional papers
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Practice Recommendations:

Diagnostic evaluation:
1.

2.

History: Include (a) characteristics of the seizure, (b) duration, (c) focal attributes such
as sidedness, (d) recent immunizations, and if immunization status is current, (e) family
history of seizure and or developmental delay, (f) loss of consciousness.
Physical Exam (PE)/Monitoring: General physical exam and neurological exam,
status of fontanelle (age dependent), muscle tone and or strength.

Diagnostics:

1. Only to diagnosis the cause of the fever
2. Neurodiagnostic evaluation is not indicated in the routine evaluation of a simple febrile seizure
aside from identifying the source of the fever.

Treatment:
1.
2.

Only to treat the cause of the fever
Neurological treatment is not indicated after a simple febrile seizure aside from treating the
underlying cause of fever.

Discharge Criteria:
1. The patient is back to baseline with a non-focal neurological examination
2. The likely source of the fever has been identified and treated
3. A treatment plan with appropriate follow up has been devised
Outcome Measures:
1. PowerPlan Use
2. Length of Stay in the ED
3. CT with or without contrast
Potential Cost Implications: The goal of the Simple Febrile Seizure Management CPG is to reduce
cost by decreasing unnecessary interventions for this population.
Potential Organizational Barriers: Education of staff and parental anxiety and expectations
Supporting Documentation
PowerPlan- See Appendix A
Team Recommendations:
Question 1a: Should the child with a simple febrile seizure have laboratory tests performed?
Simple Febrile Seizure CPG Team recommendation:
The Simple Febrile Seizure CPG team concurs with the recommendation of the AAP not be
performed as part of a routine evaluation of a simple febrile seizure (Duffner et al., 2011).
Specifically the AAP guideline states serum electrolytes, calcium, phosphorus, magnesium, blood
glucose or a complete blood cell count “should not be performed in the routine evaluation of the
child with a simple febrile seizure”. The recommendation is based on evidence from observational
studies. Teran, Medows, Wong, Rodriguez, & Varghese (2012) evaluated the usefulness of obtaining
a CBC in children with a simple febrile seizure. They report 134/182 (73%) had a normal CBC,
42/182 (23%) had leukocytosis, and 6/182 (4%) had leucopenia. We value identifying the source of
the fever, and treating the cause of the fever appropriately.
Literature supporting this recommendation
Duffner et al. (2008)
Teran et al. (2012)
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Question 1b: Should the child with a simple febrile seizure have radiological imaging (CT, MRI)?
Simple Febrile Seizure CPG Team recommendation:
The Simple Febrile Seizure CPG team concurs with the recommendation of the AAP (Patricia K
Duffner et al., 2008) that states neuroimaging “should not be performed in the routine evaluation of
the child with a simple febrile seizure”. Observational studies are the basis of the recommendation.
Furthermore, the American College of Radiology (ACR Guideline, 2012) states there is no indication
for imaging in simple febrile seizures. No additional studies have been found since the search
completed for the AAP Guideline was performed. We value identifying the source of the fever, and
treating the cause of the fever appropriately. We also value decreasing radiation exposure that
occurs with CT scanning, and the risk from sedation and cost associated with MRI.
Literature supporting this recommendation
Duffner et al. (2008)
Milla et al., (2012)
Question 1c: Should the child with a simple febrile seizure have an EEG?
Simple Febrile Seizure CPG Team recommendation:
The Simple Febrile Seizure CPG team concurs with the recommendation of the AAP Guideline
(Duffner et al. 2008) that an EEG should not be performed in the child who is neurologically healthy
and has had a simple febrile seizure. Two additional studies have been found since the search
completed for the AAP Guideline was performed and included here. They are both are of
retrospective cohort studies and do not provide additional information that supports obtaining an
EEG for children after a simple febrile seizure. Both studies look at the prognostic value of obtaining
an EEG and neither study separates simple from complex febrile seizures to answer this question.
Kanemura, Sano, Yamashiro, Sugita, & Aihara (2011) reported on 119 subjects (99 subjects had
simple febrile seizures) Those with simple febrile seizures were significantly less likely to develop
epilepsy (p<0.05). However the EEG was performed 7-20 days after the index event, not the
population we are including in this CPG. (Karimzadeh et al., 2013) did not differentiate simple from
complex seizures.
Literature supporting this recommendation (See Tables 2 and 4)
Duffner et al. (2008)
Kanemura, Sano, Yamashiro, Sugita & Aihara (2011)
Karmzadeh et al. (2012)
Question 1d: Should the child be treated with medications for seizure?
Simple Febrile Seizure CPG Team recommendation:
The Simple Febrile Seizure CPG team concurs with the statement made in AAP Guideline (Duffner et
al. 2008) that simple febrile seizures are benign events, and not assoicated with neurological
consequences. Therefore, seizure medications are not recommended for the child who presents
after a simple febrile seizure.
Question 1 e: Should the child be sent home with medications for seizure recurrence?
Simple Febrile Seizure CPG Team recommendation:
The Simple Febrile Seizure CPG team concurs with the statement made in AAP Guideline (Duffner et
al. 2008) that simple febrile seizures are benign events, and not assoicated with neurological
consequences. Seizure medications are not recommended at the time of discharge for community
use as abortive therapy for potential recurrence of a simple febrile seizure.
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Question 1f: For the child with a simple febrile seizure should neurology be consulted?
Simple Febrile Seizure CPG Team recommendation
No literature was found to answer this question. However, the Clinical Practice Guideline published
by the AAP (Patricia K Duffner et al., 2008) states that a simple febrile seizure does not usually
require further evaluation, other than finding the source of the fever and treating the cause of the
fever appropriately.
Literature supporting this recommendation
Duffner, et al. (2008)
Question 1g: Should the child with a simple febrile be admitted to the hospital?
Simple Febrile Seizure CPG Team recommendation
The Clinical Practice Guideline published by the American Academy of Pediatrics (Duffner et al.,
2008) states one of the goals of the Guideline is to “reduce the costs of physician and emergency
department visits, hospitalization and unnecessary testing.” An objective of the Seattle Children’s
Febrile Seizure Guideline is to reduce the admission rate from the ED by 10% within one year of
Guideline implementation.
The Seattle Children’s Guideline ("Febrile Seizure v.1.1: ED Management," 2011), the British
Columbia Guideline (GPAC, 2010) state indications for admission include (a) infections that require
treatment with IV antibiotics, (b) significant caregiver anxiety, and (c) barriers to transportation to
home.
We did not identify studies that used Hospital Admission as an outcome when reporting on the care
of the child with a simple febrile seizure.
We recommend that the neurologically healthy child should not be admitted to the hospital, unless
caregiver anxiety is a barrier to providing care to the child, or transportation home from or back to
the hospital is not available.
Literature supporting this recommendation
Duffner, et al (2011)
Seattle 2011
GPAC 2010
Should a lumbar puncture and laboratory testing of CFS be done for children not up to date with HiB
and Streptococcus pneumoniae immunizations?
We concur with the AAP (Duffner 2011) Clinical Practice Guideline do not recommend the routine
performance of a lumbar puncture and laboratory testing of CSF for children who present to the ED
following a simple febrile seizure. When considering the source of the infection that caused the
fever, if meningitis is on the differential diagnosis list, a LP is warranted. We have included four
retrospective cohort studies that reinforce the low yield of positive results from an examination of
CSF in this population.
Literature supporting this recommendation (see Table 4)
Saeed (2011)
Tavasoli, Afsharkhas, & Edraki (2014)
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Guideline Preparation: This guideline was prepared by The Office of Evidence Based Practice (EBP)
in collaboration with content experts at Children’s Mercy Hospitals and Clinics. Development of this
guideline supports the initiative of the Department of Clinical Effectiveness to promote care
standardization that builds a culture of quality and safety that is evidenced by measured outcomes. If
a conflict of interest is identified, the conflict will be disclosed next to the team member’s name. The
Hospital Medicine team member was the source of input from the General Pediatrics
Team Members:
Team leaders:
Britton Zuccarelli, MD, Neurology Fellow
Team members:
Cheryl Chadwick, Coordinator, Family-Centered Care
Ibad Siddiqi, PharmD Pharmacy
Rebecca Fahlgren, DO Physician, ED and Urgent Care
Ali Fenton-Church, MD, FAAP, Physician, Hospital Medicine
Robin Lund, MD, Pediatric Resident
Laura Diddle, BS, IS Analyst
Office of Evidence Based Practice
Jeff Michael, DO, FAAP, Medical Director of Evidence Based Practice
Jacqueline Bartlett, PhD, RN, Director of Evidence Based Practice
Jarrod Dusin, MS, RD, LD, CNSC, Evidence Based Practice Program Manager
Nancy Allen, MS, MLS, RD, LD, Evidence Based Practice Program Manager
Librarian
Keri Swaggart, MLIS, AHIP
Guideline development funded by:
No external funding was obtained in the development of this guideline.
Development Process:
The review summary documents the following steps:
Review of existing internal and external guidelines and standards. The AGREE II Tool is used
to assess guideline quality. It assesses the methodology of guideline development. An AGREE
II score is composed of the scores of six domains, with various numbers of items in each
domain. It is reported as a percent of the maximum score for that domain. Ideal AGREE II
Scores are not established. Application of the scores are user dependent.
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Table 2

Agree II Scoring of the AAP Guidelines for Neurodiagnostic Evaluation and Long Term Management of
Simple Febrile Seizures

Domain 1 –
SCOPE AND PURPOSE
Domain 2 STAKEHOLDER
INVOLVEMENT

AAP Duffner Long- term
management 2008

AAP Duffner 2011 Neurodiagnostic

93%

100%

76%

44%

72%

98%

92%

100%

38%

88%

20%

83%

5.5

7

Domain 3 –
RIGOR OF
DEVELOPMENT
Domain 4 –
CLARITY AND
PRESENTIATION
Domain 5 APPLICABILITY
Domain 6 –
EDITORIAL
INDEPENDENCE
Overall Guideline
Assessment (range 1-7,
higher better)

Note: Based on the AGREE Scores for the AAP Guidelines for Neurodiagnostics (Duffner, et al. 2011)
and long term management (Duffner 2008) these two guidelines were selected as the basis for this
guideline. The score is the mean percentage of four reviewers.

1. Review preparation
a. PICOT (Patient, Intervention, Comparison, Outcome, Type of question) questions established
b. Team leaders confirmed search terms employed by the Health Science Medical Librarians,
reviewed article titles and abstracts from the search, and identified articles to be read and
synthesized by the Evidence Based Practice Scholars.
2. Databases searched
a. AHRQ National Guideline Clearinghouse
b. Cochrane
c. Medline
d. CINAHL
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e. EMBASE
3. Critically analyze the evidence
a. Guidelines
AGREE criteria were used to analyze published clinical guidelines. (Table 2)
b. Single studies
i. The EBP Scholars used the Cochrane Collaborative’s electronic software, Review
Manager 5 (RevMan), to produce systematic reviews of the evidence of the effects of
healthcare and delivered these documents to the team for review. RevMan allowed the
EBP Scholars to build the tables of study characteristics, tables of study biases, and
analyze study data in a meta-analysis
ii. When meta-analyses were found in the literature search, or created in RevMan, the
GRADE criteria evaluated the literature using the Cochrane Collaborative’s electronic
software known as GRADEprofiler (GRADEpro). GRADEpro assesses the meta-analysis
for:
1. Limitations in study design and execution
2. Inconsistency between studies
3. Indirectness of study outcomes
4. Imprecision
5. Publication bias
iii. The Appendix B defines how the quality of the evidence is rated and how the
recommendation is established based on the type of evidence.
4. Recommendations for the guideline that were developed by a consensus process incorporated the
three principles of EBP (current literature, content experts [CPG Team], and patient and family
preference [when possible]).
Approval Process: Guidelines are reviewed and approved by an internal reviewer, Grant Latta, DO and
an external reviewer, Dr. Michelle K. Hughes, DO. The reviewers each completed the AGREE II Tool on
the guideline and the result is in Table 3.
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Table 3.

Agree II Scoring for the Simple Febrile Seizure Clinical Practice Guideline
Simple Febrile Seizure Clinical Practice Guideline
Domain 1 –
SCOPE AND PURPOSE
Domain 2 - STAKEHOLDER
INVOLVEMENT
Domain 3 –
RIGOR OF DEVELOPMENT
Domain 4 –
CLARITY AND PRESENTIATION
Domain 5 - APPLICABILITY
Domain 6 –
EDITORIAL INDEPENDENCE

94%
86%
88%
89%
90%
79%

Note: the score is the mean percentage of two reviewers
The CPG Team comprised of content expert clinicians, the Office of EBP, Medical Executive Committee
and other appropriate hospital committees as deemed suitable for the guideline’s intended use.
Guidelines are reviewed and updated as necessary every 3 years within the Office of EBP at CMH&C. The
CPG Team will be involved with every review and update.
Disclaimer:
The content experts and the Office of EBP are aware of the controversies surrounding the management
of the pediatric patient in xxx. When evidence is lacking or inconclusive, options in care are provided in
the guideline and the power plans that accompany the guideline.
These guidelines do not establish a standard of care to be followed in every case. It is recognized that
each case is different and those individuals involved in providing health care are expected to use their
judgment in determining what is in the best interests of the patient based on the circumstances existing
at the time.
It is impossible to anticipate all possible situations that may exist and to prepare guidelines for each.
Accordingly these guidelines should guide care with the understanding that departures from them may be
required at times, although a discussion with an Endocrinologist is recommended prior to this occurring
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Table 4:

Characteristics of included studies :
Kanemura 2011
Methods
Participants

Interventions

Outcomes

Retrospective cohort study, Japan Their question was if EEG characteristics, especially localization of paroxysmal
discharges predict subsequent epilepsy.
Number of subjects: 128 subjects met the criteria; Nine were excluded because they did not meet the criteria for
follow-up. (N= 119)
Patients were referred by on outpatient department 1-3 weeks after the febrile seizure.
Inclusion criteria: Definition of a febrile seizure for this study is a seizure accompanied by fever without an obvious
central nervous system invasive infection in child including neonatal seizures only
Exclusion criteria: history of afebrile seizures, marked dehydration, or seizures after immunizations. Children with acute
or remote neurologic insults
Definition of complex seizure: one or more of the following: the seizure lasted > or = 15 minutes, focal seizure, more
than one seizure with a 24 hour time period
EEG on a 12- or 16- channel instrument 7-20 days after the index illness, when the subject was afebrile..The EEG lasted
at least 20 minutes. The EEG included intermittent photic activation and hyperventilation was used when the subject
could perform the tasks. Two pediatric neurologists interpreted the EEGs; a third opinion was sought when there was
disagreement. All subjects were followed for more than four years.
Diagnosis of Febrile Seizure: 26 (21.8%) subjects showed a paroxysmal abnormality on EEG and 9 (7.6%) developed
epilepsy.
Subjects with simple febrile seizures were significantly less likely to develop epilepsy than those with complex febrile
seizures OR= 0.29 95% CI [0.11, 0.80] p< 0.05
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Karimzadeh 2013
Methods: Before/After study. participants had an EEG done shortly after a febrile seizure, then again 2
weeks later
Participants

Setting: Mofid Children's Hospital ED in Iran
Number of participants: Not randomized, 58 patients presented with possible febrile seizure
Completed: 36, further broken down into 23 with simple febrile seizure and 13 with complex febrile
seizure
Gender: 66% male
Inclusion Criteria: age 6 months-6 years, presenting with febrile seizure
Exclusion criteria: children with previous nonfebrile seizure, patients with evidence of intracranial
infection, patients with electrolyte imbalance, patients who were not referred for second EEG
Power analysis: not mentioned

Interventions

Two EEGs were done on each patient while under sedation with 50-75mg/kg oral chloral hydrate: 1)
24-48 hours after febrile seizure and 2) two weeks after seizure.

Outcomes

EEG abnormality immediately after seizure
EEG abnormality two weeks after seizure
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Notes

All patients were sedated with chloral hydrate for both EEGs.
This study had no control (in other words, no participants were studied that were seizure-free)
All participants participated in both EEGs.
Some patients were not counted as participants for this study because they were not referred for a
second EEG, it is unclear whether these participants had a normal EEG the first time and were
therefore not referred.
This study was "focused on the timing of the EEG recording after seizure" and "concluded no
association between abnormal eliptiform discharge and early-late EEG recording".
the study further breaks down the types of EEG abnormalities, which show some differences between
early and late EEGs.
Results: 29/36 (80.6%) of early EEGs showed abnormalities. This result does not differentiate
between patients with simple febrile seizures and those with complex febrile seizures.
25/36 (69.4%) of late EEGs showed abnormalities. This result does not differentiate between patients
with simple febrile seizures and those with complex febrile seizures.
For the 13 patients with complex febrile seizure, 3 had a normal early EEG.
Information is given linking family history of febrile seizure and early EEG abnormality at 100%
The study showed a 7/10 correlation between early EEG abnormality and complex febrile seizure in age
< 3 years and a 100% correlation between early EEG abnormality for age 3+. No mention is made of
correlation between late EEG abnormality and age.
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Saeed 2014
Methods
Participants

Interventions
Outcomes
Notes

Retrospective cohort record review
Setting: Pediatric neurology department at Children's Hospital Taif in Saudi Arabia
Age: 272 children between 6 months and 5 years of age
Completed: 272 pediatric charts were reviewed.
Gender: 39% male
Inclusion criteria: Children who presented with first febrile seizure as identified by reviewing the admission registers
Exclusion criteria: Children with other neurological diseases like cerebral palsy, mental retardation, past history of
meningitis with sequel, other neurological diseases, and fever after occurrence of seizures or antibiotics for more than 48
hours.
Power analysis: not provided
Reviewed charts of those children admitted to the ED with a seizure and had an LP. Fever defined as a temperature of>/=
38 C (recorded in emergency, OPD or in the ward).
6 children out of 272 (2%) were diagnosed to have meningitis.
The findings of this retrospective review confirms previously reported probability of bacterial meningitis is 0.45-1.25 (Carroll
& Brookfield, 2002).

Tavasoli 2014
Methods
Participants

Interventions

Retrospective Cohort
Participants: Charts of all patients meeting inclusion criteria from October 2000-2010 were reviewed.
Setting: Ali-Asghar Children's Hospital, Iran.
Randomized: not randomized, cohort study
Age: 26 months (SD=2.7months)
Completed:681 patients with febrile seizure were identified, 422 had lumbar puncture.
Gender: 4% male
Inclusion Criteria:
Patients 1 month -6 years of age presenting to the hospital with complaint of fever and seizure.
Exclusion Criteria:
Patients with a history of previous non-febrile seizures, or a previously diagnosed underlying illness associated with seizures,
an immune compromised state, or the presence of a ventriculoperitoneal shunt or trauma.
Charts were reviewed to evaluate use of lumbar puncture and results to determine presence of bacterial meningitis
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Outcomes

Outcomes evaluated:
Meningitis, bacterial or aseptic
Results:
· A total of 681 patients with a diagnosis of FS were identified.
· An LP was performed in 422 patients (62%).
· Diagnosis of meningitis (bacterial or aseptic) was identified in 19 cases (4.5%, 95% CI 2.9–6.9). The mean age of
the patients with meningitis was 10±3.2 months including 11 males (58%).
· Seven patient met the study criteria for bacterial meningitis (1.65%, 95% CI 0.8–3.3).
· All patients with bacterial meningitis had complex febrile seizures. Impaired consciousness was seen in 15 cases
with meningitis (78.9%) and 6 cases with bacterial meningitis (85.7%) compared with 26 cases with a normal LP
(6.5%) and this was statistically significant.

Notes

The findings of this retrospective review confirms previously reported probability of bacterial meningitis is 0.45-1.25 (Carroll
& Brookfield, 2002).

Teran 2012
Methods
Participants

Outcomes

Retrospective cohort study
Setting: cared for in a the ED or admitted to the inpatient unit of a community hospital in a urban location. Records were
retrieved from Jan 2004 to Dec 2009 (6 years) US
Number included: 219 subjects 182 with simple febrile seizure and 37 with complex febrile seizure
Gender: 62.1% male
Age: mean age 22.9 =/- 13.2 months
Inclusion criteria: diagnosed with simple of complex febrile seizure in the ED
Exclusion criteria: if the discharge diagnosis changed from the admission diagnosis
For the Simple Febrile Seizure Group
Radiology
· 156/182 (92%) had a normal chest x-ray
CBC
· 134/182 (73%) had a normal CBC
· 42/182 (23%) had leukocytosis
· 6/182 (4%) had leukopenia
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Excluded Studies and Reason for Exclusion
Study
Carapetian et al. (2015)
Frank et al. (2012)
Gamirova (2013)
Kimia et al. (2010)
Kuang et al. (2014)
Lee (2012)
Schreiber et al. (2012)
Vazquez and Fenton (2011)

Reason for exclusion
Survey of US Emergency Departments and their compliance to the AAP guidelines
Complex febrile seizure
Abstract only
Complex febrile seizure
Complex febrile seizure
Abstract only
Abstract
Abstract only
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Appendix A
Power Plan
Unique Plan Description: EDP Simple Febrile Seizure
Plan Selection Display: EDP Simple Febrile Seizure
PlanType: ED/UCC
Version: 1
Begin Effective Date: 03/14/2016 09:13
End Effective Date: Current
Available at all facilities
EDP Simple Febrile Seizure
Vital Signs/Monitoring
Vital signs
CR monitor
Frequency: Continuous, RN to change limits Yes, Upper HR limit 185, Lower HR limit 95,
Upper RR limit 70, Lower RR limit 20, Cardiorespiratory Leads 3 [Less Than 6 month(s)]
(DEF)*
Frequency: Continuous, RN to change limits Yes, Upper HR limit 180, Lower HR limit 85,
Upper RR limit 60, Lower RR limit 15, Cardiorespiratory Leads 3 [6 - 36 month(s)]
Frequency: Continuous, RN to change limits Yes, Upper HR limit 150, Lower HR limit 60,
Upper RR limit 50, Lower RR limit 12, Cardiorespiratory Leads 3 [3 - 11 year(s)]
Frequency: Continuous, RN to change limits Yes, Upper HR limit 140, Lower HR limit 20,
Upper RR limit 35, Lower RR limit 10, Cardiorespiratory Leads 3 [Greater Than or Equal
To 11 year(s)]
Frequency: Continuous, RN to change limits Yes, Upper HR limit 200, Lower HR limit
100, Upper RR limit 70, Lower RR limit 20, Cardiorespiratory Leads 5, Cyanotic Cardiac
BP
Upper Systolic Limit: 110, Lower Systolic Limit: 60, Upper Diastolic Limit: 60, Lower
Diastolic Limit: 30, Upper MAP Limit: 75, Lower MAP Limit: 40 [6 - 24 month(s)] (DEF)*
Upper Systolic Limit: 120, Lower Systolic Limit: 70, Upper Diastolic Limit: 80, Lower
Diastolic Limit: 30, Upper MAP Limit: 90, Lower MAP Limit: 45 [3 - 10 year(s)]
Upper Systolic Limit: 140, Lower Systolic Limit: 80, Upper Diastolic Limit: 90, Lower
Diastolic Limit: 40, Upper MAP Limit: 105, Lower MAP Limit: 50 [Greater Than or Equal
To 11 year(s)]
Upper Systolic Limit: 95, Lower Systolic Limit: 55, Upper Diastolic Limit: 60, Lower
Diastolic Limit: 35, Upper MAP Limit: 70, Lower MAP Limit: 40 [Less Than 6 month(s)]
Nutrition/Diet
NPO diet
Regular diet for age
Nursing
Suction by Nurse
Lumbar puncture set up
Respiratory
Pulse oximetry/oxygen ED
Laboratory
CBCD
Blood Culture
Urinalysis & Microscopic if UA pos (No Culture)
Urine Culture
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Blood glucose monitoring POC
Urine dipstick POC
Add on Test
CSF Labs
Cell Count CSF
LP, Urgent collect, T;N
CSF Culture & Gram Stain
CSF Lumbar Puncture, Urgent collect, T;N
Glucose Level CSF
Cerebrospinal Fluid, Urgent collect, T;N
Protein Level CSF
Puncture, Urgent collect, T;N
HSV 1/2 PCR CSF
Cerebrospinal Fluid, Urgent collect, T;N
Radiology
zzChest AP LAT
CT
If complex seizure and if history or exam is focal, consider CT Head w/o Contrast(NOTE)*
CT Head or Brain w/o Contrast
Continuous Medications/Fluids
IV placement
NS fluid bolus
20 mL/kg, IV, IV Soln, 1 time only (DEF)*
10 mL/kg, IV, IV Soln, 1 time only
LR fluid bolus
20 mL/kg, IV, 1 time only (DEF)*
Comments: Infuse Over:
10 mL/kg, IV, 1 time only
Comments: Infuse Over:
D5W NS
IV
Medications
acyclovir
Anti-pyretics
acetaminophen
10 mg/kg, PO, 1 time only [Less Than 100 kg] (DEF)*
Comments: Max Dose: 1 Gm /dose
12.5 mg/kg, PO, 1 time only [Less Than 80 kg]
Comments: Max Dose: 1 Gm /dose
15 mg/kg, PO, 1 time only [Less Than 66 kg]
Comments: Max Dose: 1 Gm /dose
ibuprofen
10 mg/kg, PO, 1 time only (DEF)*
Comments: Max Dose: 800 mg/ dose
100 mg, PO, 1 time only
200 mg, PO, 1 time only
300 mg, PO, 1 time only
400 mg, PO, 1 time only
600 mg, PO, 1 time only
800 mg, PO, 1 time only
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Antibiotics
cefTRIAXone
50 mg/kg, IV, 1 time only
Comments: Max dose: 2 grams
cefTRIAXone / lidocaine for IM
50 mg/kg, IM, 1 time only
Comments: This entry is diluted with lidocaine 1% and contains less than 10 mg
of lidocaine per mL in final dilution. Max dose: 2 grams
vancomycin in D5W (standard)
10 mg/kg, IV, 1 time only (DEF)*
Comments: MAX DOSE: 1 gram/dose
15 mg/kg, IV, 1 time only
Comments: MAX DOSE: 1 gram/dose
500 mg, IV, 1 time only
1,000 mg, IV, 1 time only
vancomycin in NS (for dextrose restricted patients)
10 mg/kg, IV, 1 time only (DEF)*
Comments: MAX DOSE: 1 gram/dose
15 mg/kg, IV, 1 time only
Comments: MAX DOSE: 1 gram/dose
500 mg, IV, 1 time only
1,000 mg, IV, 1 time only
Topicals
J-Tip with buffered lidocaine 1%
0.2 mL, Intradermal, Unscheduled, PRN Needle Sticks
AneCream 4% topical cream
1 application, Topical, Cream, Unscheduled, Needle Sticks
Medical Supplies
Manometer Disposable Pharmaceal Eac
*Report Legend:
DEF - This order sentence is the default for the selected order
GOAL - This component is a goal
IND - This component is an indicator
INT - This component is an intervention
IVS - This component is an IV Set
NOTE - This component is a note
Rx - This component is a prescription
SUB - This component is a sub phase

The Office of Evidence Based Practice, 2016
Center of Clinical Effectiveness
Contact information bzuccarelli@cmh.edu or jmichael@cmh.edu

21

January 20, 2016
Appendix B
Grading of CPG Recommendations
Grade of
Confidence in
Recommendation
Clarity of Benefits
vs. Harms, Burden,
and Cost
Strong recommendation Desirable effects
High quality evidence
clearly outweigh
undesirable effects or
vice versa
Strong recommendation Desirable effects
Moderate-quality
clearly outweigh
evidence
undesirable effect or
vice versa

Quality of Supporting Evidence

Implications

Consistent evidence from well-performed
RCTs or exceptionally strong evidence
from unbiased observational studies

Recommendation can apply to most patients in
most circumstances. Further research is
unlikely to change our confidence in the
estimate of effect
Recommendation can apply to most patients in
most circumstances. Further research (if
performed) is likely to have an important effect
on our confidence in the estimate of effect and
may change the estimate.

Evidence from RCTs with important
limitations (inconsistent results,
methodological flaws, indirect evidence,
or imprecise results) or unusually strong
evidence from unbiased observational
studies
Evidence for at least 1 critical outcome
from observational studies, from RCTs
with serious flaws or indirect evidence

Strong recommendation
Low-quality evidence

Desirable effects
clearly outweigh
undesirable effect or
vice versa

Strong recommendation
Very-low-quality
evidence
(Very rarely applicable)

Desirable effects
clearly outweigh
undesirable effect or
vice versa

Evidence for at least 1 of the critical
outcomes from unsystematic clinical
observations or very indirect evidence

Recommended
High-quality evidence

Desirable effects
closely balanced with
undesirable effects

Consistent evidence from well-performed
RCTs or exceptionally strong evidence
from unbiased observational studies
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Recommendation may change when higherquality evidence becomes available. Further
research (if performed) is likely to have an
important influence on our confidence in the
estimate of effect and is likely to change the
estimate.
Recommendation may change when higherquality evidence becomes available; any
estimate of effect, for at least 1 critical
outcome, is uncertain.
The best action may differ, depending on
circumstances or patients or societal values.
Further research is unlikely to change our
confidence in the estimate of effect.
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Recommended
Moderate-quality
evidence

Desirable effects
closely balanced with
undesirable effects

Evidence from RCTs with important
limitations (inconsistent results,
methodological flaws, indirect evidence,
or imprecise results) or unusually strong
evidence from unbiased observational
studies
Evidence for at least 1 critical outcome
from observational studies, from RCTs
with serious flaws or indirect evidence

Alternative approaches likely to be better for
some patients under some circumstances.
Further research (if performed) is likely to have
an important influence on our confidence in the
estimate of effect and may change the
estimate.
Recommended
Desirable effects
Other alternatives may be equally reasonable.
Low-quality evidence
closely balanced with
Further research is likely to have an important
undesirable effects
influence on our confidence in the estimate of
effect and is likely to change the estimate.
Recommended
Desirable effects
Evidence for at least 1 critical outcome
Other alternatives may be equally reasonable.
Very-low-quality
closely balanced with
from unsystematic clinical observations or Any estimate of effect, for at least 1 critical
evidence
undesirable effects
very indirect evidence
outcome, is uncertain.
Adapted from: Schunemann, H. J., Vist, G. E., Jaeschke, R., Kunz, R., Cook, D. J., & Guyatt, G. (2002). Advanced topics in moving from evidence
to action: Grading recommendations. In Guyatt, G., Rennie, D., Meade, M. O., & Cook, D. J.(Ed.), Users’ guides to the medical literature: A
manual for evidence-based clinical practice (pp 679-701). New York, NY:McGraw-Hill.
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